Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 200 results
ILCN article
TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and COVID-19
ILCN article
Lung Cancer Considered - Episode XXV - Mar 16, 2020 Dr. Marty Edelman Speaks With IASLC President Dr. Tetsuya Mitsudomi
ILCN article
Journal Radar: Robust Survival Duration Shown in NSCLC With Pembrolizumab
ILCN article
JAVELIN Lung 200: Potential Reasons for Avelumab’s Failure to Provide OS Benefit
ILCN article
c-MET Antibody–Drug Conjugates: Misconceptions Corrected, Excitement Explained— An Interview with Dr. Karen Kelly
ILCN article
An Interview with Dr. Federico Cappuzzo: Checkpoint Inhibitors Have Replaced Old Strategies
ILCN article
Thoughts on IMpower 150: Latest FDA Approval for Atezolizumab Misses the Mark
ILCN article
The IASLC Fight Against Lung Cancer in Peru and Latin America
ILCN article
Dr. Howard 'Skip' Burris III Shares His Views on Clinical Trial Eligibility Criteria, Payer Involvement
ILCN article
Q&A with Dr. D. Ross Camidge
ILCN article
Keeping It Personal: CMS-Proposed Coverage Restrictions for NGS Challenge Innovation in Personalized Care
ILCN article
Q&A with TMB Expert Dr. Solange Peters
Pagination
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page